Testing for Alzheimer Disease Biomarkers and Disclosing Results Across the Disease Continuum
Sign Up to like & getrecommendations! Published in 2023 at "Neurology"
DOI: 10.1212/wnl.0000000000206891
Abstract: Three pathologic processes are characteristic of Alzheimer disease (AD): β-amyloid, hyperphosphorylated tau, and neurodegeneration. Our understanding of AD is undergoing a transformation due to our ability to measure biomarkers of these processes across different stages… read more here.
Keywords: biomarker; disease; alzheimer disease; biomarkers disclosing ... See more keywords